Abitec Corporation, a specialty lipid manufacturer, has expanded its custom synthesis capabilities to include high-purity lipids for lipid nanoparticle (LNP) therapeutics.   The comprehensive bench-to-patient service offering will address key market challenges, including limited availability of cGMP-grade lipids and unpredictable lead times. LNP developers in pharma, biotech, and academia will now be able to efficiently overcome their toughest lipid chemistry challenges and drive their LNP the...